Music Therapy at TMH Infusion Center

NCT06450626 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-02-03

No results posted yet for this study

Summary

The goal of this clinical trial is to test the effects of a listening music intervention on the symptom burden carried by patients who are receiving infusions at the Lifespan Cancer Institute of Miriam Hospital in Providence, Rhode Island. The main questions it aims to answer are:

* Will a music therapy intervention help reduce physical and mental symptom burden?
* Will a music therapy intervention be beneficial on physiological parameters during the infusion sessions, such as heart rate, respiratory rate, and blood rate?

Participants will undergo the following main tasks:

* Prior to the infusion, participants will be given a pre-assessment survey reflecting on their previous experiences with infusions.
* During the infusion, participants will listen to a self-selected playlist either on their own device or on an iPad provided by the clinic, and vitals will be monitored.
* After the session, participants will be given a post-assessment survey to evaluate outcomes of the intervention.
* Participants will also be asked a set of qualitative questions about their overall experience with the music therapy session.

Conditions

  • Music Therapy

Interventions

OTHER

Listening Music Intervention

Participants will listen to a music playlist while vitals are monitored, along with completing a pre- and post-assessment survey (both of which are the Edmonton Symptom Assessment Scale). Participants will also be asked a set of qualitative questions about their overall experience with the music therapy session.

Sponsors & Collaborators

  • The Warren Alpert Medical School of Brown University

    collaborator UNKNOWN
  • Brown University

    lead OTHER

Principal Investigators

  • Fred J Schiffman, MD · Brown University

  • Diana A Wang, BA · Brown University

  • Claire Lin, BA · Brown University

  • Ishaani Khatri, BA · Brown University

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-19
Primary Completion
2024-09-30
Completion
2024-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06450626 on ClinicalTrials.gov